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Consumption of “gluten-containing” diet causes disease for a signifi cant minority of people who consume foods 
derived from wheat, rye, barley, and possibly oat. The fact is, however, that in several types of diseases related to the 
consumption of “gluten-containing” cereals, the trigger compounds are not components of gluten. The current view 
of medical experts is that, excluding people suffering from celiac disease, the majority of individuals who are feeling 
better on the “wheat-free” or “gluten-free” diet could select a food containing much healthier, low level of 
fermentable oligosaccharides (often called as FODMAP). To satisfy the specifi c health related demands of certain 
consumer groups, the challenge is in front of cereal breeding to develop new, “healthier” germplasms, suitable to 
produce such products by the food industry. This report aims to give an overview of some aspects of recent 
developments in this booming area, (i) summarizing the up-to-date knowledge on cereals-related health disorders; 
(ii) reporting on the status of developing celiac-safe cereals, and fi nally (iii) highlighting the potential of developing 
“healthier” spelt-based cereal products through the progress in an ongoing spelt breeding program.
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Based on the defi nition of ISLAM and co-workers (2011), wheat gluten is a protein-lipid-
carbohydrate complex formed as a result of specifi c covalent and non-covalent interactions 
among fl our components during dough making as the components are hydrated and energy 
from mechanical input from the mixing process is provided. However, nowadays the terms 
‘gluten’ and ‘gluten-free’ are used more widely (and wrongly) in everyday practice, the latter 
loosely referring to food products not containing cereal prolamin proteins, i.e. wheat gliadin 
and glutenin analogues.
Consumption of “gluten-containing” food causes disease for a signifi cant minority of 
people who consume foods derived from wheat, rye, barley, and possibly oats. The 
consideration of oat as a “harmless cereal” is one of the oldest and open problems among 
experts. While several publications explain its potential danger as a result of contamination 
by other cereal, others claim that a certain proportion of celiac patients are sensitive to 
epitopes found in avenins, the storage proteins of oat (PULIDO et al., 2009; COMINO et al., 
2016).
The fact is that in several types of diseases related to the consumption of “gluten-
containing” cereals, the trigger compounds are not components of gluten. There is a lack of 
detailed knowledge about the causes of different symptoms or diseases and the terms “gluten”, 
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“prolamins”, “gliadin”, “glutenin” not only in the minds of the consumer but also in medical 
practice (BRANCHI et al., 2015).
The general public in most Western countries is now aware of the potential adverse 
effects of cereals containing gluten with reports appearing in the lay press (BRALY & HOGGAN, 
2002; FORD, 2008; WANGEN, 2009) promoting gluten-free diets. Many of these reports fail to 
draw attention to the importance of appropriate diagnosis or defi ning the nature of the gluten 
“intolerance” an individual may have, hence posing a signifi cant public relations threat to the 
grain industry.
Gluten-free business has been booming in the last fi ve years in western countries. In the 
USA retails sales reached $10.5 billion in 2013, and more than $15 billion is predicted for 
2016. In Australia, where more than 23% of new bakery products were marketed as gluten-
free in 2014, it is expected that the gluten-free retail sales exceed $100 million in the next fi ve 
years (JARGON, 2014).
As the knowledge about the mechanisms of certain disorders is improving, we learn that 
the causing components of cereal products are not always gluten proteins but often soluble 
proteins (albumins and globulins), even soluble oligosaccharides. This fact underlines the 
need to understand better what type of diet is required for different sensitive individuals 
instead of only recommending “gluten-free” diet for them.
Commercial activity related to “gluten toxicity” and “wheat allergy” is mostly focused 
on “gluten-free” food. However, as more and more information is collected in the medical 
research, for medium or long term, the solution to solve this problem and satisfy what the 
different consumer groups need does not simply have traditional and “gluten-free” products 
on the shelf of the supermarkets. A gluten-free diet is not healthier but incomparably more 
expensive than the consumption of gluten-containing products (MISSBACH et al., 2015). 
Beyond those individuals who suffer from celiac disease (~1% of the Caucasian population), 
consumers with different cereal-related health disorders can tolerate products containing 
reduced and/or altered gluten content and reduced amounts of certain soluble carbohydrates 
(FODMAPs) (HALMOS et al., 2015).
To satisfy the specifi c health related demands of particular consumer groups, the 
challenge is in front of cereal breeding to develop new, “healthier” germplasms, suitable to 
produce such products by the food industry.
To defi ne approachable goals, a better understanding of the different health related 
disorders, their prevalence and causing compounds is required not only in the relevant basic 
research but also in commercial cereal breeding. This report aims to give an overview of 
some aspects of recent developments in this booming area, summarizing the up-to-date 
knowledge on cereals-related health disorders, providing some information on the status of 
developing celiac-safe cereals, fi nally – by offering an example of the progress in an ongoing 
spelt breeding program – highlighting the potential of developing “healthier” spelt-based 
cereal products.
1. Cereal-related health disorders
The spectrum of “gluten”-related disorders can be divided into three main groups: 
autoimmune, allergic, and not autoimmune - not allergic disorders (SAPONE et al., 2012). Two 
of these disease types, the autoimmune and the allergic diseases are relatively well 
documented; however, further studies are needed to reveal mechanisms related to the various 
symptoms of allergic reactions. The autoimmune disorders include celiac disease (CD) 
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(ANDERSON & WIESER, 2006), gluten ataxia, and dermatitis herpetiformis (LAURIÈRE et al., 
2006). The allergic reactions involve respiratory allergy (AMANO et al., 1998), food allergy 
(MILLS et al., 2004), wheat-dependent exercise-induced anaphylaxis (ARMENTIA et al., 1990), 
and contact urticaria (LAHTI, 1986). The adaptive and innate pathways leading to CD-specifi c 
symptoms have been described and reviewed extensively (PLUGIS & KHOSLA, 2015).
1.1. Celiac disease
Symptoms of celiac disease are triggered by an abnormal response of auto-antibodies, such 
as antibodies to tissue-transglutaminase, or antibodies against proline- and glutamine-rich 
wheat gluten proteins or their barley and rye homologs (GREEN & CELLIER, 2007). Celiac 
disease shows strong association with HLA-DQ alleles, one of the most important genetic 
factors in developing detrimental symptoms (SOLLID et al., 2012). HLA-DQ heterodimers 
function as surface-type receptor proteins bound to the surface of antigen-presenting cells. 
The presence of HLA-DQ molecules, such as DQ2.5, DQ8, DQ2.2, is a clear marker for 
developing autoimmune symptoms, with modifying effects coming from genetic and 
environmental factors (ANDERSON et al., 2000). The different serotypes recognise different 
peptides.
A set of criteria can be defi ned for the structure of an active CD epitope in a cereal 
protein: a) a size of nine amino acids fi tting into the groove of the HLA-DQ heterodimers, b) 
the presence of a tissue transglutaminase 2 (tTG) enzyme-binding site, c) surrounded by 
amino acids with defi ned charge and hydrophobicity (SOLLID et al., 2012). Patients suffering 
from celiac disease produce a range of autoimmune responses to gliadins and LMW glutenins 
and several HMW glutenin subunits as well as their analogous polypeptides in the consumed 
cereal products (JUHÁSZ et al., 2012).
1.2. Wheat allergies
The development of wheat allergies is mediated more directly by the recognition of allergens 
by specifi c IgE epitopes bound to mast cells (CATASSI & FASANO, 2008). Depending on the 
route of wheat allergen exposure, symptoms can be divided into symptoms of classic food 
allergy; Wheat-dependent exercise-induced anaphylaxis (WDEIA); occupational asthma 
(bakers’ asthma), and urticaria (SAPONE et al., 2012). Typical food allergy symptoms may 
affect the skin, gastrointestinal or respiratory tract. Bakers’ asthma, one of the most common 
respiratory allergies, is a signifi cant symptom among adults working with wheat fl our.
In wheat allergy, allergen-presenting B-cells and T-cells have the same level of impact 
and, similar to other food allergies allergic reactions, are the result of cross-links between 
specifi c immunoglobulin E and short peptides rich in glutamine and proline that arise from 
the breakdown of wheat seed proteins by endogenous proteases (SAPONE et al., 2012). This 
interaction stimulates basophils and mast cells to release chemical mediators, such as 
histamines resulting in different categories of infl ammatory reactions. The allergenic regions 
of proteins recognised by the binding sites of IgE molecules are called IgE-binding epitopes. 
These epitopes can be classifi ed into two categories, conformational and linear epitopes and 
both types are involved in the development of allergic reactions (AKAGAWA et al., 2007). 
Allergenic proteins of wheat are not only prolamins (α, β, γ, and ω gliadins, HMW, and LMW 
glutenin subunits) but also proteins that are not components of the gluten complex (amylases, 
the lipid transfer proteins (LTP), peroxidase, thioredoxin, and serine proteinase inhibitors) 
(TATHAM & SHEWRY, 2008).
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1.3. Non-celiac gluten sensitivity
Non-celiac gluten sensitivity (NCGS) was described 40 years ago, being defi ned as mainly 
abdominal symptoms related to ingestion of gluten-containing cereals (SCHUPPAN et al., 
2015). There is substantial evidence that NCGS is caused by an innate immune response to 
wheat proteins (different from the adaptive, T cell-mediated response to gluten in celiac 
disease, or to gluten and non-gluten proteins in wheat allergy) (SAPONE et al., 2012; CATASSI 
et al., 2013). The study carried out by JUNKER and co-workers (2012) led to the identifi cation 
of the family of amylase-trypsin inhibitors (ATIs) as triggers of innate immunity in wheat. 
NCGS has become a topic of increasing interest for the scientifi c community. The results of 
the survey of BRANCHI and co-workers (2015) demonstrate a certain degree of awareness of 
the clinical relevance of gluten-related disorders among gastroenterology specialists.
1.4. Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a common gastrointestinal condition contributing to 
considerable fi nancial burden and impact on quality of life. Till recently, therapeutic strategies, 
however, had disappointing effi ciency but it is improved signifi cantly by the fi ndings of the 
research group led by Peter Gibson, Melbourne, Australia (GIBSON et al., 2007, 2015). 
Because many abdominal symptoms might originate from bowel digestion altering factors 
that contribute to luminal digestion, particularly the osmotic load within the lumen, and the 
fermentative gas content might offer symptomatic benefi t. Candidate substrates that are 
highly fermentable exerting an osmotic effect are dietary, poorly absorbed, short-chain 
carbohydrates collectively termed FODMAPs (Fermentable Oligosaccharides, Disaccharides, 
Monosaccharides, and Polyols) (SHEPHERD & GIBSON, 2006). FODMAPs can include fructose 
and lactose in patients in whom these are malabsorbed polyols such as sorbitol because they 
are poorly absorbed by humans, as well as fructo-oligosaccharides (fructans) and galacto-
oligosaccharides (such as raffi nose) for which humans do not express suitable hydrolases and 
are always poorly absorbed (SHEPHERD et al., 2008). Major dietary FODMAPs include 
fructose and fructans. Common dietary sources of fructose are fruit and honey; sources of 
fructans are cereals and onion (MUIR et al., 2009; BIESIEKIERSKI et al., 2011).
The evidence base for the effi cacy of the low FODMAP diet is building (SHEPHERD & 
GIBSON, 2006; SHEPHERD et al., 2008) with a recent blinded placebo-controlled crossover 
study confirming previous studies that about 75% of patients gain clinically significant 
benefit (HALMOS et al., 2014). The low-FODMAP diet is increasingly being applied by health 
professionals in patients with IBS as first-line therapy (HALMOS et al., 2014, 2015). Given the 
high prevalence and chronic nature of IBS, it is possible that many people will restrict intake 
of FODMAPs over months to years (SHEPHERD & GIBSON, 2006).
1.5. Prevalence of different disorders
Overall, celiac disease affects 1% of Western communities in which the predisposing genes, 
HLA DQ2 and HLA DQ8, are found in approximately 30% of the population (ANDERSON & 
WIESER, 2006).
Recently a large set of blood samples from randomly selected individuals (n=1145) 
(PASCO et al., 2012) was analysed by the IgE RAST method against wheat and milk antigens, 
and food allergy questionnaires were used with statistical analyses to establish relationships 
between individuals with clinical symptoms and immune responses (VU et al., 2014). Results 
indicated that the prevalence of wheat allergy was 2.5% where both a positive IgE immune 
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response and symptoms against wheat were observed. These results are in full agreement 
with similar investigations on wheat where the prevalence of wheat IgE sensitization in 
European countries is 2.9% (ZUIDMEER et al., 2008; SILES & HSIEH, 2013). It was postulated 
that the remaining 12.8% (n=125) of individuals who showed raised IgE antibody levels 
without symptoms might have a latent wheat sensitivity with the potential of developing 
symptoms sooner or later. The large proportion (12.9%) of the investigated population who 
have symptoms associated with consumption of wheat products but did not demonstrate 
raised IgE may suffer from other wheat-related disorders (i.e. not IgE mediated) such as 
celiac disease, non-celiac gluten sensitivity (NCGS), or reaction to fructans (FODMAPs) for 
those with IBS.
2. Developing celiac-safe wheat
The amino acid sequences of gluten proteins that are responsible for triggering responses in 
sensitive individuals have been identifi ed showing that they vary in distribution among and 
between different groups of gluten proteins (SHEWRY & TATHAM, 2016). The detection and in 
particular the quantifi cation of gluten proteins are critical not only due to their direct effect 
on end-use quality but also for food safety reasons. Grain composition varies between cereal 
genotypes and therefore leads to methodological problems in food allergen research and 
genotype selection in breeding for quality. The high sequence similarity and multi-species 
origin of prolamins coupled with limitations in the available methodologies, reviewed by 
HARASZI and co-workers (2011) make the accurate identifi cation of proteins that trigger health 
problems and their genotypic frequency, variability and stability diffi cult to determine. High-
resolution methods such as mass spectrometry (MS) require accurate quantitative relationships 
between prolamin peptide biomarkers and the fi nal gluten/prolamin content to relate the 
detection of peptide mass to their protein sources. These quantitative relationships, however, 
are diffi cult to establish due to genotypic and environmental variability.
To assist peptide biomarker searches, epitope mapping, protein selection and medical 
studies, a database (ProPepper, https://propepper.net) was developed to contain members of 
the prolamin superfamily proteins identifi ed from Poaceae species, peptides obtained with 
single and multi-enzyme in silico digestion as well as linear epitopes responsible for wheat-
related food disorders (JUHÁSZ et al., 2015).
Knowledge of the composition and amounts of toxic and allergen epitopes present in a 
single wheat sample represents a signifi cant gap and the very soon complete grain proteome 
datasets now available can provide the necessary information to carry out an estimation of 
toxicity/allergen prediction for a single cultivar. The combined use of genome sequence and 
toxic/allergen databases, prediction methodology, and cereal chemistry results in a better 
understanding of the level of toxicity present in the end-products from wheat fl our. The 
workfl ow presented in the review of JUHÁSZ and co-workers (2012) provides information 
about the number and distribution of epitopes for a single protein or a protein fraction. Also, 
epitopes present in the highest frequency and for the most harmful proteins can be identifi ed. 
The “epitope toxicity” value obtained in this way is a signifi cant research output from the 
analysis of large datasets that can be applied to the food industry.
Recently two valuable reviews summarized current research activities focusing on the 
status of alternative cereals and pseudocereals and their derivatives obtained by natural 
selection, breeding programs, and transgenic or enzymatic technology, with the potential to 
develop products tolerated by celiac people (COMINO et al., 2013; SHEWRY & TATHAM, 2016). 
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Conventional breeding may, therefore, be used to select for gluten protein fractions with 
lower contents of celiac epitopes. Molecular breeding approaches can also be used to 
specifi cally down-regulate celiac-toxic proteins or mutate celiac epitopes within individual 
proteins. One of the known examples of this approach is the work of GIL-HUMANES and co-
workers (2008, 2010), where RNA interference mediated gene silencing was used to down-
regulate the gamma and the alpha gliadins in bread wheat. Similar approach was used by 
ALTENBACH and co-workers (2014a, b) to eliminate the most allergenic gluten proteins, the 
omega-5 gliadins.
The combination of the above approaches may, therefore, be used to develop “celiac-
safe” wheat. However, this remains a formidable challenge due to the complex multigenic 
control of gluten protein composition. Furthermore, any modifi ed kinds of wheat must retain 
acceptable properties for making bread and other processed foods. Not surprisingly, such 
celiac-safe wheat has not yet been developed despite over a decade of research.
3. Gluten-free versus low FODMAP diet
In a recent survey (GLUTEN-FREE FOODS IN THE U.S., 5th Edition, 2012) of those who eat 
gluten-free foods, 36% do so for reasons other than sensitivity, 65% because they think it is 
healthier, 27% because they believe that it aids weight loss, 7% do so to help reduce 
infl ammation, and 4% do so to combat depression, only 5.7% claimed a formal medical 
diagnosis.
Gluten-free diet (GFD) generates many social and economic repercussions due to the 
ubiquity of gluten in foods (COMINO et al., 2013). Meanwhile, it cannot be regarded as a 
healthy diet (BALAKIREVA & ZAMYATNIN, 2016). Gluten-free products are usually made with 
starches or refi ned fl ours characterised by low fi bre content. It is known that the consumption 
of adequate amounts of dietary fi bre is related to signifi cant health benefi ts such as prevention 
of colon cancer, diabetes, and cardiovascular disease. Thus, GFD may lead to possible 
nutrient defi ciencies in fi bre resulting in consequent diseases. Several studies suggest pseudo-
cereal sources of fi bre instead of gluten-free products to maintain the necessary fi bre content 
level (SATURNI et al., 2010). GFD also leads to a defi ciency in vitamins C, B12, D, and folic 
acid (HALLERT et al., 2002), as well as microelements, most importantly calcium, magnesium, 
and zinc (CARUSO et al., 2013). At the same time, GFD contains high amounts of sugar and 
hydrogenated fats, which could result in the occurrence of hyperinsulinemia and an increased 
obesity risk (LAMACCHIA et al., 2014). Thus, GFD appears to be an unbalanced diet inadequate 
regarding both macro- and micronutrients. The current view of medical experts is that, 
excluding people suffering from celiac disease, the majority of individuals who are feeling 
better on the ‘wheat-free’ or ‘gluten-free’ diet are automatically selecting a low FODMAP 
diet because of choosing ‘gluten-free’ products (HALMOS et al., 2014, 2015).
Realization of the crucial importance of FODMAP components about food-related 
health disorders initiated active research and development in analysing FODMAP-content, 
as well as utilizing food materials with low FODMAP content. Compared to the ‘gluten-free’ 
phenomena, where the problematic food sources are a relatively small group of certain 
cereals, the establishment of a low FODMAP diet involves considering a much wider range 
of plant-origin foodstuffs. In the last fi ve years, publications (MUIR et al., 2007, 2009; 
BIESIEKIERSKI et al., 2011) and even computer and mobile phone applications (http://www.
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med.monash.edu.au /cecs/gastro/fodmap/iphone-app.html) have been published to help to 
develop custom-designed low FODMAP diets.
Traditional cereals (wheat, barley, and in particular rye) are relatively rich in FODMAPs 
and therefore food products made from them are not recommended for low FODMAP diets.
Compared to bread wheat, spelt (Triticum aestivum subsp. spelta) contains signifi cantly 
lower amounts of fructose and fructans. But even more important is that there is around a 
fi vefold larger inter-varietal difference among spelt varieties compared to those found among 
bread wheat genotypes (BÉKÉS, 2015). It provides the basis for screening the spelt cultivars 
for low FODMAP content.
4. Spelt, a nutritive cereal
Molecular evidence indicates that spelt (T. aestivum ssp. spelta (L.) Thell.) (2n=6x=42, 
genome=AABBDD) are derived from hybridization events between non-free threshing 
tetraploid wheat (2n=4x=28, genome=AABB) and free-threshing hexaploid wheat. Most of 
the hulled wild wheats and hexaploid subspecies such as spelta, macha, and vavilovii have a 
recessive allele (q) at the Q locus that conditions major domestication traits in wheat (FARIS, 
2014). Extensive systematic breeding and selection led to the development of free-threshing 
and high-yielding varieties of spelt-wheat having the wide adaptability to different agro-
climatic conditions and resulted in the replacement of most of the low-yielding traditional 
landraces and subspecies. Now, in most parts of the world, spelt has been superseded by 
common wheat (T. aestivum ssp. aestivum) and is being grown as a marginal or niche crop 
with low inputs. After many years of marginal cultivation, recent interest in the use of spelt 
for ecologically grown food has led to a resurgence in its cultivation. In fact, the food use of 
spelt has been a tradition in Europe, particularly in Germany where it is widely used in many 
grain-based foods (CUBADDA & MARCONI, 2002). In the last 10–15 years several excellent 
works have been published in relation to the evolution, genetics, physiology, and the G × E 
effects on quality of spelt (BLATTER et al., 2004; FÖRSTER et al., 2013, 2014).
Spelt demonstrates a higher resistance to environmental factors than common wheat and 
can be cultivated in harsh ecological conditions, without the use of pesticides (RAMAN et al., 
2008). Moreover, spelt can grow on poorly drained and low-fertility soils and therefore is a 
suitable crop for organic farming (BONAFACCIA et al., 2002). In the past, spelt has not been 
targeted for systematic breeding; the objectives for improvement have only recently been 
identifi ed (NEESON et al., 2008).
In the last decade, spelt is becoming a valuable crop due to its reputation as a healthy 
food not for celiacs but especially for patients with wheat allergies (GALOVA & KNOBLOCHOVA, 
2001; ELÍA et al., 2004) and in confectionary. Spelt fl our is also reputed to possess a unique 
fl avour and to be more nutritious than bread wheat (CAMPBELL, 1997). Generally, spelt 
products such as bread attract a higher price in the marketplace, especially organic products.
The chemical, nutritive, and functional properties of spelt wheats compared to T. 
aestivum wheats have been reported in numerous publications in the last decade, reviewed 
recently by ESCARNOT and co-workers (2012). Results showed that, on average, spelt whole 
meals and milling fractions were higher in lipids and unsaturated fatty acids as compared to 
wheat, whereas tocopherol content was lower in spelt, suggesting that the higher lipid content 
of spelt may not be related to a higher germ proportion. Although milling fractionation 
produced similar proportions of fl our and bran in spelt and wheat, it was found that ash, 
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copper, iron, zinc, magnesium, and phosphorus contents were higher in spelt samples, 
especially in aleurone-rich fi ne bran and in coarse bran. Even though phosphorus content was 
higher in spelt than in wheat brans, phytic acid content showed the opposite trend and was 
40% lower in spelt versus wheat fi ne bran, which may suggest that spelt has either a higher 
endogenous phytase activity or a lower phytic acid content than wheat. The results of the 
study of RUIBAL-MENIETA and co-workers (2005) give important indications of the real 
nutritional value of spelt compared to wheat. Moreover, it was shown by GOMEZ-BECERRA and 
co-workers (2010) that the Ca/Fe ratio, combined with that of oleate/palmitate, provides a 
highly discriminating tool to authenticate spelt from wheat fl ours and to face the growing 
issue of spelt-fl our adulteration. The results indicated that spelt is a highly promising source 
of genetic diversity for grain protein and mineral nutrients, particularly for Zn and Fe.
The spelt-based products are easily digestible and have a slightly higher protein content 
than wheat. The main difference in the nutritive value of spelt fl ours is the variation in the 
amount and type of grain proteins, especially the prolamins (GALLI et al., 2000; SHEWRY, 
2002). There has been anecdotic clinical evidence for a long time that a large proportion of 
non-celiac disease patients suffering from wheat-related health disorders can tolerate products 
made from certain spelt varieties. Recently the fi rst research paper with robust experimental 
and statistical results also demonstrated this important observation (ARMENTIA et al., 2012).
Because FODMAP components are located mostly in the endosperm of the grains, 
reducing the milling yield, producing less bran in the fl our, does not improve the FODMAP 
level. The baking technology, on the other hand, has a signifi cant effect because yeast 
metabolizes a certain amount of soluble carbohydrates during fermentation. So, FODMAP 
content in the fi nal product can be altered both by the amount of yeast applied in the bread 
formulation, and/or the length of fermentation. Compared to yeasted dough products, 
sourdough technology has an even more signifi cant effect in reducing the FODMAP level.
5. Breeding less allergenic spelt-wheat with low FODMAP content
An Australian selected and grown spelt line (“GWF spelt”) was successfully selected with 
signifi cantly lower FODMAP content. The FODMAP content of the baking products of this 
line – using an optimised formulation and technology – was considerably lower than the 
threshold defi ned for low FODMAP products (MUIR et al., 2014).
Interestingly, the same line was found to have signifi cantly less immune reactivity than 
any wheat and other spelt cultivars to people suffering from wheat sensitivity (VU et al., 
2014). It was also found that the albumin-globulin protein composition of GWF spelt is 
different from other wheat and wheat-related species (VU, 2014). One of these differences 
has been identifi ed as a mutation in a CACTA retrotransposon region tightly linked to a gene 
coding a beta-expansin protein in many wheat and spelt germplasms (BREEN et al., 2010). The 
beta-expansins, a protein family of closely related non-enzymatic proteins found in plant cell 
walls, are known pollen allergens. This alteration in the soluble protein composition was 
claimed to be one of the reasons for the signifi cantly lower immune reactivity of GWF spelt 
for wheat sensitive individuals (VU et al., 2014). The mutation in the expansin gene alone 
does not explain the lower immune reactivity but could be utilised as a marker for the unusual 
soluble protein composition found in GWF spelt. This altered protein composition could be 
related to the lower immune reactivity, observed.
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The potential candidate source for making cereal products with dual health benefi ts has 
been recognised by several bakeries in Australia. A closed production line has been developed, 
including contract growing of GWF spelt with strict guidelines to avoid any contamination 
of the grain. A small milling capacity has been established with a particular care of cleaning 
the whole technology prior GWF spelt milling. A PCR-based procedure has been developed 
to detect the above-mentioned mutation in the expansin gene (SUTER & BÉKÉS, 2012) to 
screen for any contamination in the grain or fl our samples caused by any other cereals with 
the wild type expansin protein. This procedure is utilised for quality assurance purposes. 
FODMAP content of fl our and their products (sourdough bread with unique formulation) is 
monitored by an expert laboratory. Flour from this unique spelt source, characterised by low 
FODMAP and lower immune reactivity, is currently being supplied to Australian artisan 
bakeries under the name of Hildegard spelt fl our, after St Hildegard von Bingen, nun, writer, 
composer, philosopher, Christian mystic, visionary, and polymath from the 11th century who 
fi rst realised the health related advantages of spelt.
Preliminary experiences provide some evidence to support the dual health benefi ts of 
this spelt line. The question remains as to whether this fi nding is associated with the apparent 
lower allergenicity of spelt for those with wheat allergy. An answer requires a double-blind, 
randomized placebo-controlled clinical trial, comparing the allergic symptoms and IgE levels 
caused by the consumption of wheat and GWF spelt products, involving both, those that eat 
predominantly wheat and those who have replaced spelt for wheat in their diet.
Based on the positive experiences on evaluating GWF spelt, a pre-breeding activity has 
been initiated in Hungary to screen large spelt populations, selecting lines with low FODMAP 
content and suitable processing quality. The chosen lines are further investigated by looking 
for genotypes containing the expansin-mutation applying the PCR-based test of SUTER and 
BÉKÉS (2012) and ELISA based techniques (BODINIER et al., 2008), respectively. As it is 
demonstrated in a preliminary survey carried out on 105 spelt lines (PAUK et al., unpublished 
results), FODMAP content of spelt lines available in the Carpathian basin show large 
variation (0.7–1.8 g fructan in 100 g grain). More than 10% of the lines contain equal or 
lower level of fructan than the Australian control, found to be benefi cial in low FODMAP 
diet.
To increase the speed of generation changing in breeding and to improve the homogeneity 
of newly selected spelt-lines an effective in vitro androgenesis method was developed in spelt 
wheat (LANTOS et al., 2016). The anther culture method was carried out with a new Hungarian 
genotype (GK Fehér), but the protocol was tested by other three spelt registered varieties, 
too. The production of embryo-like structures (ELS) was 62 ELS/100 anthers, from which 
we were able to regenerate green plantlets. The percentage of green plantlets production was 
89.0% among the regenerated plantlets while the number of albinos was limited (3.8/100 
anthers). Altogether, over one-thousand in vitro green plantlets were produced from anther 
culture of different spelt genotypes. Based on ploidy-level analyses from the haploid plantlets 
the doubled haploid plantlets were produced via colchicine treatment (PAUK et al., 2003) and 
getting seed after spontaneous diploidization. The colchicine treated and spontaneous DH 
plants were grown up in the greenhouse. The in vitro haploid induction system was integrated 
into the breeding programme of spelt-wheat in the same way as we did in common wheat 
(PAUK et al., 2004).
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6. Conclusions
The above procedure of producing a cereal line with health benefi ts can be used as an 
example, indicating how to manage (protect, monitor, and check) the quality of the fi nal 
product from contamination by any other cereal material from the fi eld to the bakery. This 
type of issues will hopefully appear shortly when germplasm with altered gluten and/or non-
gluten protein composition and proven reduced allergenicity will be selected or produced.
Compared to the ultimate task – developing celiac-safe cereals – it is a much more 
realistic approach to developing cereals with largely reduced allergenicity and with low 
FODMAP content. Such products can be consumable for most of the wheat sensitive 
customers but not for the celiac patients.
The development, manufacturing and commercial availability of such products require 
further detailed basic and applied research in relation to developing reliable, cost-effective, 
and high-throughput analytical tools to monitor the presence/absence and quantity of certain 
key components of the source material, the intermediates, and the fi nal product through the 
whole production chain from the farm to the supermarket. However, the development of the 
infrastructure for the production and commercialization of a more versatile, healthier cereal 
product basis is one of the several requirements needed to deal with the complex issue of 
providing suitable food for people suffering from cereal-based health disorders. The 
legislative environment must be altered to allow the production/commercialization of 
products with low/altered gluten content, defi ning thresholds of certain key components, 
giving instructions of analytical procedures, labelling, regulating, and policing the very often 
misleading media-based marketing, etc. But ultimate need is the better communication, 
collaboration among plant science, medical research and practice, as well as grain industry 
and the permanent, honest, and up-to-date information of the customer.
*
This study was supported within project OTKA-K_16-119835, funded by the National Research, Development and 
Innovation Offi ce.
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